Artiva Biotherapeutics, Inc. Quarterly Depreciation in USD from Q2 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Artiva Biotherapeutics, Inc. quarterly Depreciation history and growth rate from Q2 2023 to Q3 2024.
  • Artiva Biotherapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $600K, unchanged year-over-year.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $600K $0 0% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $600K +$100K +20% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-29
Q3 2023 $600K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $500K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.